P
US11028102B2ActiveUtilityPatentIndex 59

Methods of using 1-O-acetylbritannilatone spiro aryl isoxazoline compounds

Assignee: XIAN TAIKOMED PHARMACEUTICAL TECH CO LTDPriority: Dec 15, 2017Filed: Feb 29, 2020Granted: Jun 8, 2021
Est. expiryDec 15, 2037(~11.5 yrs left)· nominal 20-yr term from priority
Inventors:TANG YONGHONGCHANG MINGHUIQI HUAFENGLIANG CHENGYUANJU XINGKETIAN LEILIU YUZHILI HAN
A61P 11/06C07D 498/10C07D 495/04A61P 29/00
59
PatentIndex Score
0
Cited by
0
References
2
Claims

Abstract

A method of inhibiting leukotriene include: administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject,R1 is OH or OAc; X is C or N; and R2 is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO2, or halogen, provided that when X is N, R2 is nil.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method of inhibiting leukotriene comprising:
 administrating a therapeutically effective amount of a compound of chemical formula I or II or a pharmaceutical acceptable salt thereof to a subject, 
 
       
         
           
           
               
               
           
         
         wherein R 1  is OH or OAc; X is C or N; and R 2  is H, alkyl, alkoxy, benzyloxy, haloalkyl, OH, CN, NO 2 , or halogen, provided that when X is N, R 2  is nil. 
       
     
     
       2. The method of  claim 1 , wherein X is C and R 2  is H, F, Cl, Br, CN, CH 3 , OCH 3 , NO 2  or OH.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.